Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures by DI LIDDO, Rosa et al.
JOURNAL OF 
NEUROINFLAMMATION
Di Liddo et al. Journal of Neuroinflammation  (2015) 12:23 
DOI 10.1186/s12974-015-0248-1RESEARCH Open AccessAnti-inflammatory activity of Wnt signaling in
enteric nervous system: in vitro preliminary
evidences in rat primary cultures
Rosa Di Liddo1*†, Thomas Bertalot1†, Anne Schuster2, Sandra Schrenk2, Alessia Tasso1, Ilenia Zanusso1,
Maria Teresa Conconi1† and Karl Herbert Schäfer2†Abstract
Background: In the last years, Wnt signaling was demonstrated to regulate inflammatory processes. In particular,
an increased expression of Wnts and Frizzled receptors was reported in inflammatory bowel disease (IBD) and
ulcerative colitis to exert both anti- and pro-inflammatory functions regulating the intestinal activated nuclear factor
κB (NF-кB), TNFa release, and IL10 expression.
Methods: To investigate the role of Wnt pathway in the response of the enteric nervous system (ENS) to
inflammation, neurons and glial cells from rat myenteric plexus were treated with exogenous Wnt3a and/or LPS
with or without supporting neurotrophic factors such as basic fibroblast growth factor (bFGF), epithelial growth
factor (EGF), and glial cell-derived neurotrophic factor (GDNF). The immunophenotypical characterization by flow
cytometry and the protein and gene expression analysis by qPCR and Western blotting were carried out.
Results: Flow cytometry and immunofluorescence staining evidenced that enteric neurons coexpressed Frizzled 9
and toll-like receptor 4 (TLR4) while glial cells were immunoreactive to TLR4 and Wnt3a suggesting that canonical
Wnt signaling is active in ENS.
Under in vitro LPS treatment, Western blot analysis demonstrated an active cross talk between canonical Wnt
signaling and NF-кB pathway that is essential to negatively control enteric neuronal response to inflammatory
stimuli. Upon costimulation with LPS and Wnt3a, a significant anti-inflammatory activity was detected by RT-PCR
based on an increased IL10 expression and a downregulation of pro-inflammatory cytokines TNFa, IL1B, and
interleukin 6 (IL6). When the availability of neurotrophic factors in ENS cultures was abolished, a changed cell
reactivity by Wnt signaling was observed at basal conditions and after LPS treatment.
Conclusions: The results of this study suggested the existence of neuronal surveillance through FZD9 and Wnt3a
in enteric myenteric plexus. Moreover, experimental evidences were provided to clarify the correlation among
soluble trophic factors, Wnt signaling, and anti-inflammatory protection of ENS.
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In the last two decades, enormous progress has been
made in the characterization of soluble factors that re-
gulate gut functionality at physiological and inflamed
conditions. Among signaling molecules, Wnt family pro-
teins (Wnts) are reported to play a pivotal role in the
development of gut [1,2] balancing the homeostasis
of intestine epithelium [3]. After the binding of Wnt
ligands with the G protein-coupled receptor Frizzled
(FZD) and single-span low-density lipoprotein receptor-
related protein (LRP) [4,5], β-catenin is released from
the large destruction “scaffolding” complex consisting of
Axin, adenomatous polyposis coli (APC), casein kinase 1
(CK1), glycogen synthase kinase 3β (GSK3β) complex, and
shuttles to the nucleus promoting the transcription of
target genes [http://www.stanford.edu/~rnusse/wntwindow.
html]. Moreover, under active inhibition induced by GSK3β
or cross talked pathways [6-9], β-catenin is trapped at the
plasma membrane or is tagged by phosphorylation for
ubiquitin-mediated degradation [10].
Wnt ligands and Frizzled members have been largely
studied in animal and human tissues [4,11]. Although the
expression of Wnts, Frizzled, and Wnt-Frizzled binding
specificities is well defined in epithelial and mesenchymal
gut compartments [3], so far they have been poorly inves-
tigated in the enteric nervous system (ENS). The control
of canonical Wnt pathway on intestinal tract has been first
hypothesized observing β-catenin stabilization in familial
and sporadic colon cancers [12]. Furthermore, significant
evidences have demonstrated that Wnt ligands control the
proliferation, differentiation, and self-renewal of intestinal
crypt progenitor cells [13-15], in both paracrine and auto-
crine fashion [16]. As suggested by the increased expres-
sion of Wnts and Frizzled receptors in inflammatory
bowel disease (IBD) and ulcerative colitis [17], Wnt sig-
naling is involved in gut inflammation and exerts both
anti- and pro-inflammatory functions. In particular, β-ca-
tenin has shown to i) negatively regulate intestinal NF-кB
activity in bacterial-induced epithelial inflammation [18],
ii) reduce TNFa release [19], and iii) induce the expression
of IL10 and TGFB [20] while the activation of pro-
inflammatory mediators seems to be correlated to nonca-
nonical Wnt signaling [21].
The course of Wnt FZD signaling is dictated by the
specificity of Wnt-FZD interactions, which is in turn
governed by both cell type and stage of development
[16,22-24]. Expressed in the dorsal neural tube at the
time of neural crest emigration [25], Wnt3a activates
β-catenin target genes that are involved in several pro-
cesses such as the positioning/maturation of Paneth cells
and the proliferation and differentiation of colonic stem
cell compartment [3,26,27] but also the maintenance
and expansion of enteric neural crest progenitor cells
[28]. As the release of Wnt3a increases in response togut mucosa injury and inflammatory bowel diseases
[29-31], the activation of canonical signaling pathway by
Wnt3a could be hypothesized as an active mechanism in
ENS.
Several studies have reported that Wnts preferentially
activate the signaling pathway binding with defined mem-
bers of FZD family according to a specific tissue dis-
tribution. Similarly to other Wnt ligands [32,33], a wide
spectrum of FZD binding affinities for Wnt3a has been re-
ported including FZD1 [19], FZD4, FZD5, and FZD8 [34].
Among recently investigated Frizzled receptors, FZD9 has
been detected early during the development of the mouse
nervous system [35] and this expression pattern is highly
conserved like in chicken and zebrafish [36]. When FZD9
is activated by Wnt2, it leads to a Wnt/β-catenin signaling
[37]. Although FZD9 is widely expressed on both multipo-
tent neuroepithelial precursor cells and neural-restricted
precursors [36,38], it was so far not yet described in the
ENS compartment.
Besides Wnt proteins, glial cell-derived neurotrophic
factor (GDNF), nerve growth factor (NGF), fibroblast
growth factors (FGF), epithelial growth factor (EGF),
leukemia inhibitory factor (LIF), interleukin 6 (IL6),
and lipopolysaccharide (LPS) from gram-negative enteric
bacteria [39-44] modulate strongly the ENS or gut func-
tion. In case congenital or acquired defects reduce the
bioavailability of enteric neurotrophic factors, a compro-
mised ENS development [45-48] and a dysfunction of
the immune system [49] are observed to promote the in-
hibition of GSK3β activity [50,51] and enterocolitis [52],
suggesting that a possible cross talk between Wnt/β-catenin
pathway and immune response could be involved.
In experimentally LPS-induced colitis, an increased
enteric glia activation [53] and neuronal cell death due
to an excessive stimulation of excitatory transmitters
[54] are reported to occur. The endotoxin LPS is an es-
sential membrane component of luminal microflora bac-
teria that interacts specifically with enteric responsive
cells through toll-like receptor 4 (TLR4) [55-57] to regu-
late intestinal homeostasis. In neuronal compartments,
low-dose LPS can contribute to maintain neuronal sur-
vival [58] and differentiation through the activation of
NF-кB, while higher doses result in excessive stimulation
of proinflammatory cytokines [59] that leads to neuronal
toxicity [60]. The involved intracellular signaling cascade
includes the phosphorylation of mitogen-activated pro-
tein kinase (MAPK) and the migration of NF-κB into
the nucleus [61]. Studies performed on enterocytes [62]
showed that the response to LPS triggers the inactivation
of GSK3β through the activation of phosphatidylinositol
3 kinase (PI3K)/Akt pathway [63,64]. There is increasing
evidence that the critical activators of NF-кB pathway,
IKKα, and IKKβ interact differently with β-catenin by
regulating its protein levels and cellular localization [65].
Table 1 Primary and secondary antibodies used for the
immunophenotypical characterization of ENS cells
Primary antibodies Manufacturing company
Mouse anti-rat NG2 FITC Santa Cruz Biotechnology, Inc
Goat anti-rat Nanog PE BD Biosciences
Mouse anti-rat CD34 PECy7 BD Biosciences
Rabbit anti-rat Sox2 Millipore
Rabbit anti-rat Sox10 Santa Cruz Biotechnology, Inc
Rabbit anti-rat TLR4 Santa Cruz Biotechnology, Inc
Goat anti-rat Frizzled 9 Santa Cruz Biotechnology, Inc
Mouse anti-rat Nestin Millipore
Mouse anti-rat GFAP Millipore
Mouse anti-rat PAN neuronal Millipore
Rabbit anti-rat p75 Millipore
Secondary antibodies
Goat anti-mouse FITC Santa Cruz Biotechnology, Inc
Goat anti-rabbit FITC Santa Cruz Biotechnology, Inc
Bovine anti-goat FITC Santa Cruz Biotechnology, Inc
Donkey anti-goat PE Santa Cruz Biotechnology, Inc
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mic and activates NF-кB by phosphorylating IкBs under
proinflammatory stimuli (TNFa, IL1, TLR agonists) [66],
IKKα is detected in both nucleus and cytoplasm at resting
state and inhibits β-catenin degradation mediated by
Axin/APC/GSK3β, as well as it induces cyclin D1 expres-
sion that is a point of convergence between the Wnt/β-
catenin and IкB pathways in mitogenic signaling [67]. As
soon as the IKK complex is activated in response to
mitogens, inflammation, apoptosis, immune response, or
cancer, IKKα is enhanced to shuttle from cytoplasmic to
nuclear compartment where it phosphorylates nuclear
p65 within the transactivation domains and promotes
the transcriptional activity of NF-кB target genes. While
IKKβ-dependent pathway is essential for activation of in-
nate immunity, IKKα-dependent pathway is more impor-
tant for the regulation of adaptive immunity [66].
Based on these evidences, the present study was focused
on the expression and activity of Wnt signaling compo-
nents such as FZD9 and Wnt3a during the ex vivo growth
of postnatal ENS cells. In particular, standard settings and
starvation of growth factors were used to simulate physio-
logical and pathological conditions, respectively, as the
availability of soluble factors is already demonstrated to
control the structural integrity and functionality of ENS.
Taking into consideration that canonical Wnt signaling
controls stem cell proliferation/differentiation [68-70] and
inflammation [71], the immunophenotypical characteri-
zation of ENS subpopulations [72], all components of
LPS/TLR4 signaling [56] and β-catenin modulatory acti-
vity on NF-кB were explored to better define the ENS
response to inflammation [73-75].
Methods
Isolation of cells from rat enteric nervous system
ENS cells (ENSc) were isolated from Sprague Dawley
rats, 3 days old as previously described [76] and under
Italian and German ethic committee authorization
(CEASA 43/2012). The isolated cells were either cul-
tured in standard (SM) [76] and basal conditions (BM)
[Neuronal Base P (PAA, Cölbe, Germany), 1% L-glutam-
ine (Sigma-Aldrich, St. Louis, MO, USA), 1% penicillin/
streptomycin (Invitrogen Life Technology, Carlsbad, CA,
USA) for 7 days before morphological analysis by optical
microscopy, immunophenotypical characterization by
flow cytometry (FCM) and Wnt signaling study by gene
expression, Western blotting (WB), protein complex im-
munoprecipitation (Co-IP), and immunofluorescence
assay (IF) were performed.
Immunophenotype characterization by FCM
The analysis was performed on ENSc at time of isolation
(T0) and after 7-day culture (T7) using the primary anti-
bodies reported in Table 1. In parallel, controls werestained using only corresponding secondary or isotypic
antibodies. Data were acquired using FACSCanto II Flow
cytometer (BD Biosciences, San Josè, CA, USA) and
FACSDiva v6.1.3 software (BD Biosciences). The positive
expression of each target marker was established using
the overton subtraction tool of Summit 4.3 software
(Beckman Coulter Inc, Brea, CA, USA).
Immunofluorescence analysis
ENS cells cultured for 7 days (T7) in SM or BM were
fixed with BD Cytofix solution (BD Biosciences), for 20
min, at 4°C. All samples were double stained with pri-
mary goat anti-rat Frizzled 9 or rabbit anti-rat TLR4
(Santa Cruz Biotechnology, Inc, Dallas, TX, USA) and,
then, indirectly conjugated with PE and FITC secondary
antibodies (Santa Cruz Biotechnology, Inc), respectively.
In parallel, single staining with primary rabbit anti-rat
Wnt3a (Cell Signaling Technology, Inc, Danvers, MA,
USA) and FITC-conjugated secondary antibody was per-
formed. As negative controls, specimens stained only
with FITC- and PE-conjugated secondary antibodies
were prepared. After mounting with Fluoro-Gel II solu-
tion containing DAPI (EMS, Hatfield, PA, USA), the
samples were analyzed using a Leica TCS SP5 confocal
microscope (Leica, Wetzlar, Germany).
Formation of neurospheres under Wnt3a and LPS
treatment
ENS cells were seeded at 16 × 103/cm2 and cultured for
14 days with or w/o 5 μg/mL LPS (Sigma-Aldrich) or 20
ng/mL Wnt3a (R&D System, Minneapolis, MN, USA).
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neurospheres was counted using an Olympus CKX 41
microscope (Olympus, Hamburg, Germany) equipped
with a Moticam 2500 and Motic Images Plus 2.0 soft-
ware (Motic, Wetzlar, Germany). In parallel, the diam-
eter of neurospheres was measured using the image
processing software ImageJ.
Wnt and LPS/TLR4 signaling pathway investigation
To investigate a possible interplay between Wnt and
PI3K/Akt signaling pathways in ENSc, nuclear and cyto-
plasmic proteins were extracted from samples cultured
in SM and BM and treated for 30 min, 1 h, and 2 h with
5 μg/mL LPS or 20 ng/mL Wnt3a. Proteins were ob-
tained using NER PER Nuclear and Cytoplasmic Extrac-
tion Reagents kit and then quantified with BCA Protein
Assay Reagent Kit (Thermo Fisher Scientific, Waltham,
MA, USA) according to the manufacturer’s protocols.
The separation of proteins was assessed by SDS/PAGE
(Bio-Rad Laboratories, Inc, Hercules, CA, USA), and the
immunoblot was carried out by overnight incubation, at
4°C, with primary rabbit anti-rat p(Ser9)-GSK3β (Cell
Signaling Technology, Inc), mouse anti-rat p(Ser473)-Akt,
β-catenin, p(Ser33)-β-catenin, NF-κB p50, and rabbit anti-
rat NF-κB p65 (Santa Cruz Biotechnology, Inc) antibodies.
The detection of target proteins was performed using
peroxidase-conjugated goat anti-rabbit and goat anti-
mouse secondary antibodies (Bio-Rad Laboratories, Inc).
The development of immunoreactivity was enhanced by
chemiluminescence substrate (ECL) (Sigma-Aldrich) and
then visualized by VersaDoc Imaging System. The protein
expression level was normalized to housekeeping protein
GAPDH (Millipore) or lamin B (Santa Cruz Biotechnology,
Inc) and quantified using the image processing software
ImageJ. Data were reported as ratio within target protein
and relative housekeeping protein expression.
Co-IP: Wnt3a/Frizzled 9 (A) and NF-κB p65/β-catenin (B)
binding assay
Total nuclear proteins were extracted from ENS cells cul-
tured for 7 days (T7) using RIPA lysis buffer. (A) Recom-
binant Wnt3a protein (R&D System, Minneapolis, MN,
USA) was added (200 ng/mL) to protein extracts and incu-
bated overnight at 4°C. The immunoaffinity purification
was performed as previously reported [77], using goat anti-
rat Frizzled 9 (Santa Cruz Biotechnology, Inc) and rabbit
anti-rat Wnt3a (Cell Signaling Technology, Inc) pre-
immobilized onto Protein A Sepharose (Sigma-Aldrich).
Western blot analysis was carried out using 4%–15% Mini
PROTEAN® TGXTM Precast Gel (Bio-Rad Laboratories,
Inc, Milan, Italy) and goat anti-rat Frizzled 9 (Santa Cruz
Biotechnology, Inc) or rabbit anti-rat Wnt3a (Cell Signaling
Technology, Inc). (B) For NF-κB p65/β-catenin binding
assay, the immunoaffinity purification was performedusing rabbit anti-rat NF-κB p65 or mouse anti-rat
β-catenin (Santa Cruz Biotechnology, Inc), pre-immobilized
onto Protein A Sepharose (Sigma-Aldrich). Both anti-
bodies were used for Western blot analysis by 6.5% poly-
acrylamide gel (Bio-Rad Laboratories, Inc).
Gene expression study: RT-PCR and qPCR
At 1 (T1) and 7 (T7) days from stimulation with Wnt3a
and LPS, total cellular RNA was extracted using TRIzol®
(Invitrogen Life Technology), quantified by measuring the
absorbance at 260 nm and then stored at −80°C until use.
Ten nanogram of RNA were reverse transcribed and amp-
lified using Qiagen One Step RT-PCR Kit (Qiagen, Hilden,
Germany) and an iCycler iQ™ (Bio-Rad Laboratories, Inc).
Primer pairs for target and housekeeping genes were
designed as reported in Table 2 and purchased from
Invitrogen Life Technology. RT-PCR products were
electrophoresed on a 2% agarose gel (Invitrogen Life
Technology) stained with GelRed™ (Biotium, Inc, Hayward,
CA, USA) and visualized using a UV transilluminator Gel
Doc 2000 Gel Documentation System (Bio-Rad Laborator-
ies, Inc). For genes reported in Table 3, the analysis was
conducted by qPCR. In particular, the reverse transcription
reaction was done with Thermoscript™ RT-PCR System
kit (Invitrogen Life Technology) and iCycler iQ™ while
the amplification reaction was carried out using Plat-
inum® SYBR® Green qPCR SuperMix UDG kit (Invitro-
gen Life Technology) and a DNA Engine Opticon® Real
Time Thermal Cycler (MJ Research, St. Bruno, QC,
Canada). The amount of gene products was calculated
using linear regression analysis from standard curves,
demonstrating amplification efficiencies ranging from
95% to 100%. Data were reported as a fold increase of
gene expression that is defined as the complementary
DNA (cDNA) ratio between target gene and reference
gene (HPRT) normalized to untreated sample. Statistical
significance was calculated by Student’s t-test comparing
to untreated samples: p value ≤0.05*, p value ≤0.01**; sam-
ples compared to LPS-treated cells: p value ≤0.01 (two
black triangles).
Results
Growth factors modulate the expression of FZD9 and
TLR4 positive cells
By flow cytometric analysis, freshly isolated ENSc
showed a heterogeneous immunophenotype with a spe-
cific stemness pattern (Figure 1A), as suggested at T0 by
the expression of Nanog (26.9 ± 0.6%), Sox2 (64.9 ± 1.4%),
Sox10 (17.7 ± 0.4%), and p75 (55.0 ± 3.2%). Multidifferen-
tiative potential of freshly isolated rat ENS cells was con-
firmed by the expression of nerve/glial antigen 2 (NG2)
(51.9 ± 4.3%), a proteoglycan typically observed on the
membrane of multipotent neural stem cells. Moreover, the
presence of nestin (24.0 ± 3.3%) and CD34 (35.9 ± 1.2%)
Table 2 Primer sequences for One-Step RT-PCR analysis
Gene Abbreviations Primer sequences Accession
Glial cell-derived neurotrophic factor GDNF F: CCAGAGAATTCCAGAGGGAAAG NM_019139.1
R: CTTCACAGGAACCGCTACAA
Epidermal growth factor EGF F: GGGCTATCCCATCGGTAATAAG NM_012842.1
R: CAGCCTCCATTCCTGTGTAA
Basic fibroblast growth factor BFGF F: AGAGGAGTTGTGTCCATCAAG NM_019305.2
R: CTCCAGGCGTTCAAAGAAGA
Nerve growth factor NGF F: CAGTGTGTGGGTTGGAGATAA NM_001277055.1
R: GCATCCACTCTCTACAGGATTC
Leukemia inhibitory factor LIF F: TGACGGATTTCCCACCTTTC NM_022196.2
R: CGTCTGTAGTCGCATTGAGTT
Hypoxanthine-guanine phosphoribosyltransferase HPRT F: GCTGACCTGCTGGATTACAT NM_012583.2
R: CCCGTTGACTGGTCATTACA
F forward, R reverse.
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shown) was correlated to the presence of an immature cell
population including neural precursors. The presence of
differentiated glial and neuronal cells was revealed by the
expression of GFAP (22.5 ± 0.6%) and PAN neuronal
(42.1 ± 1.8%), respectively. The detection of Frizzled 9Table 3 Primer sequences for qPCR analysis
Gene Abbreviatio
Toll-like receptor 4 TLR4
Wingless type MMTV integration site family, member 3A WNT3A
Frizzled 9 FZD9
Axis inhibition protein 2 AXIN2
Myelocytomatosis proto-oncogene CMYC
Jun proto-oncogene CJUN
Interleukin-1β IL1B
Interleukin-6 IL6
Interleukin-10 IL10
Tumor necrosis factor α TNFa
Hypoxanthine-guanine phosphoribosyltransferase HPRT
F forward, R reverse.(17.5 ± 3.0%) was indicative of constitutive activity of Wnt
signaling while the responsiveness of ENS populations to
LPS stimulus was suggested by the expression of TLR4
receptor (19.5 ± 0.7%). After 7 days of culture, a different
expression level of stem cell markers was observed in sam-
ples treated under simulated physiological (SM) andns Primer sequences Accession
F: ATTGCTCAGACATGGCAGTTTC NM_019178.1
R: CACTCGAGGTAGGTGTTTCTGCTAA
F: TGCAAATGCCACGGACTATC NM_001107005.2
R: AGACTCTCGGTGTTTCTCTACC
F: TACCCAGAGCGCCCTATAAT NM_153305.1
R: CAAACCCTCCTGGATCACATAC
F: ACCTATGCCTGTCTCCTCTAAC NM_024355.1
R: GTCCAGGGTATCCACACATTTC
F: CTTGGAACGTCAGAGGAGAAA NM_012603.2
R: GCTTGAACGGACAGGATGTA
F: GAAGCAGAGCATGACCTTGA NM_021835.3
R: CCATTGCTGGACTGGATGAT
F: AGTGAGGAGAATGACCTGTTC NM_031512.2
R: CGAGATGCTGCTGTGAGATT
F: GCCAGAGTCATTCAGAGCAATA NM_26744.1
R: GTTGGATGGTCTTGGTCCTTAG
F: ATTGAACCACCCGGCATCTA NM_012854
R: CAACGAGGTTTTCCAAGGAG
F: GCAGATGGGCTGTACCTTATC NM_012675.3
R: GGCTGACTTTCTCCTGGTATG
F: GCTGACCTGCTGGATTACAT NM_012583.2
R: CCCGTTGACTGGTCATTACA
Figure 1 (See legend on next page.)
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Figure 1 FCM analysis of ENSc at T0 and T7. (A) As reported by FCM analysis, freshly isolated ENSc (T0) resulted as a heterogeneous
population including stem-like, progenitor, glial, and neuronal cells. For each experimental condition, 104 cells were used for acquisition by
FACSCanto II and data were expressed as percentage (%) of positive cells ± standard deviation (SD) where each marker was compared to control
samples stained only with isotype or secondary control antibody. The positive expression was quantified using the overton subtraction tool of
Summit 4.3 software (Beckman Coulter Inc). Under SM and BM culture conditions, the aspecific modulation of glial and neuronal differentiation
was detected. (B) Immunophenotypical characterization by FCM of ENSc cultured for 7 days (T7). Data were expressed as percentage (%) of positives
(black profile) ± SD for each marker compared to corresponding staining control (gray profile). (C) FCM analysis of PAN neuronal, Frizzled 9, and TLR4
expression. Data were reported as FSC vs fluorescent marker dot plot where R1 (blue colored) and R2 (black colored) subsets were defined. The
positive expression of each target marker ± SD was discriminated in gate G1 defined with respect to staining control.
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ported, Sox2 showed to be downregulated in cells main-
tained in SM (27.2 ± 2.3%) and in BM (47.8 ± 2.9%). In
contrast, a significant increase of positivity for the pluripo-
tency marker Nanog (31.0 ± 1.9% in SM; 34.2 ± 9.6% in
BM), Sox10 (41.0 ± 1.4% in SM; 23.0 ± 3.1% in BM), and
p75 (40.5 ± 3.7% in SM; 29.6 ± 2.9% in BM) was detected.
Although unchanged in SM (15.3 ± 4.7%), a significant de-
crease of GFAP expression was detected in samples under
basal conditions (3.0 ± 0.4%). No significant alterations of
CD34 (31.3 ± 1.3% in SM; 33.7 ± 1.6% in BM) and nestin
(20.0 ± 1.8% in SM; 15.0 ± 1.7% in BM) level expression
were identified. Characterized by the expression of PAN
neuronal antigen and lower FSC value in FCM dot plots
(Figure 1C, blue-colored R2 subset), the neuronal sub-
population increased significantly in BM (40.2 ± 3.5%) with
respect to SM-treated samples (22.6 ± 3.1%). Interestingly,
the expression of Frizzled 9 (21–35 ± 2.1% in SM; 27–55
± 1.8% in BM) was restricted in neuronal population
(Figure 1C, blue-colored R2 subset). In contrast, a FCM
biparametrical analysis (FSC vs TLR4) showed that TLR4
was distributed either in neurons and glial subpopulation
(Figure 1C, black-colored R1 subset) with higher expression
in SM (40.8 ± 2.3%) compared to BM (26.8 ± 3.0%).
Frizzled 9 is coexpressed with TLR4 in enteric neurons
By immunofluorescence staining, TLR4 and Frizzled 9
were confirmed to be coexpressed only in the neuronal
subset (Figure 2A, arrows). When Co-IP was performed
to investigate whether Frizzled 9 mediates canonical
Wnt signaling, we evidenced a 107kDa band corre-
sponding by molecular weight to Wnt3a/Frizzled 9 com-
plex (Figure 2B) suggesting that Wnt3a could interact
in vivo with Frizzled 9 and promote the activation of
canonical Wnt signaling. Moreover, as cytoplasmic im-
munoreactivity for Wnt3a antibody was observed only in
glial cells, a specific regulation of neuronal reactivity was
hypothesized to be controlled by enteric glia by cano-
nical Wnt (Figure 2C).
Wnt3a and LPS enhance the proliferation of neurospheres
ENS-derived cells are usually cultured in vitro as aggre-
gates known neurospheres that, including proliferatingprogenitors, neurons, and glial cells, mimic the in vivo
niche of the gut. As growth factors and neurotrophic
stimuli are demonstrated to be essential under in vivo
settings for ENS functionality, they were used to study
the regulation by Wnt signaling on the proliferation/
differentiation of ENS cells under physiological conditions.
Typical neurospheres were detected by optical mi-
croscopy in ENS samples cultured in standard medium
(Figure 3A). From 1 (T1) to 14 (T14) days of culture,
LPS (5 μg/mL) and Wnt3a (20 ng/mL) demonstrated to
induce in SM a significant (p ≤ 0.05%) increased number
of neurospheres with higher extent in LPS-treated sam-
ples (Figure 3B,C). In parallel (Figure 3D), an enhanced
proliferation rate was indirectly evaluated measuring the
neurosphere diameter that resulted to be changed in
control samples from 33 (T1) to 54 μm (T14) while in
Wnt3a and LPS-treated samples increased from 43 (T1)
to 75 μm (T14) and from 41 (T1) to 62 μm (T14),
respectively. No neurosphere formation but several fib-
roblastoid colonies were observed in ENSc cultured in
BM. These evidences suggested that the formation of
neurospheres was strictly depending on growth factor
stimulation.
Canonical Wnt pathway is active in ENS cells and is
modulated by growth factors
When the in vivo availability of soluble factors is re-
stricted, the structural integrity of ENS is compromised
with following inflammatory diseases. Using restricted
culture conditions simulating a pathological disorder, we
better defined the ENS response to inflammation.
Both canonical pathway of Wnt signaling and LPS/
TLR4 pathway play important roles in controlling the
plasticity of ENS. Specific phosphorylation events con-
trol the active state of Akt [p(Ser473)-Akt], deactivate
GSK3β [p(Ser9)-GSK3β], and tag β-catenin for proteoso-
mal degradation [p(Ser33)-β-catenin]. In order to evalu-
ate a cross talk between Wnt and NF-кB pathways, a
protein expression analysis by WB was carried out to
evaluate the phosphorylated state of Akt, GSK3β, β-
catenin, and the nuclear translocation of both β-catenin
(n-β-catenin) and NF-кB (n-NF-кB p65, n-NF-кB p50)
(Figure 4). As phosphorylation events and cytoplasmic
Figure 2 IF analysis of TLR4 and Frizzled 9. (A) Confocal microscopy analysis evidenced the coexpression of TLR4 and Frizzled 9 on neuronal
cells (arrows) either in SM- than BM-treated samples. (B) Co-immunoprecipitation was performed on total protein extracts from ENSc cultured for
7 days in SM or BM. Immunoaffinity purification was carried out using goat anti-rat Frizzled 9 and rabbit anti-rat Wnt3a antibodies pre-immobilized
onto Protein A Sepharose. Western blot analysis was assessed using 4%–15% gradient precast polyacrylamide gel. (C) By immunofluorescence assay,
ENSc showed cytoplasmic vesicles immunoreactive (arrows) to rabbit anti-rat Wnt3a antibody. Bar: 15 μm.
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processes, WB analysis was performed using a time
course ranging from 0 (T0) to 2 h (T2h) from start of
stimulation. As shown in Figure 4A, an important mo-
dulation by supplemented growth factors was active on
Wnt and LPS pathways involving the inactivation ofGSK3β through its phosphorylation at Ser9 and the
unmasking of cytoplasmic NF-кB, respectively. More-
over, the presence of nuclear β-catenin suggested that
Wnt signal escaped from negative regulation in cytoplas-
mic compartment. Without any specific induction of Wnt
or NF-кB signaling and under starvation of growth factors
Figure 3 ENSc and formation of neurospheres. (A) After 1 day of culture, standard medium promoted the formation of neurospheres as
evidenced by optical microscopy analysis. In contrast, several fibroblastoid colonies were observed in ENS cultures maintained in BM ENS medium.
Bar: 100 μm. (B) Quantitative analysis of number and diameter of neurospheres obtained by LPS (5 μg/mL) or Wnt3a (20 ng/mL) stimulation. In parallel,
the analysis was performed on LPS- and Wnt3a-untreated samples that were used as control. Light microscopic pictures reflected the increased
number of neurospheres treated with LPS and Wnt3a after 1 (T1), 7 (T7), and 14 (T14) days in comparison to untreated cultures (control). (C) Data were
quantified and normalized to controls (100%) (n = 3). (D) Diameter of neurospheres at T1, T7, and T14 was measured (n= 150) using ImageJ software.
Statistical significance compared to control; p value ≤0.05*. Bar: 100 μm.
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GSK3β was active, and the nuclear localization of
β-catenin and NF-кB p65 was undetectable (Figure 4A).
However, after 30 min from stimulation, pAkt was effect-
ive to contrast the negative regulation induced by GSK3β
as demonstrated by the presence of β-catenin only in the
nucleus together with NF-кB p65. The cytoplasmic level
of β-catenin is controlled by Akt and GSK3β by phosphor-
ylation tagging that, in our study, was interestingly in-
creased when active Akt was more expressed (T1h, T2h)
(Figure 4A). The lacking phosphorylation of GSK3β at
Ser9 in BM-treated samples confirmed that PI3K stimula-
tion by growth factors cross talks with Wnt signaling, as
previously reported [6].
BM conditions showed to specifically discriminate the
effects of Wnt3a and LPS on ENS cells. Similar ex-
pression profiles of β-catenin, Akt, and GSK3β were
observed in samples treated with Wnt3a and LPS
(Figure 4B,C) suggesting an interplay between Wnt and
NF-κB pathways. In fact, in both cases, the activation of
Wnt signal involved the phosphorylation of GSK3β atSer9, the nuclear translocation of β-catenin and NF-κB
p65, and the phosphorylation tagging of β-catenin only
at early phase of stimulation (T30′).Wnt3a interferes with inflammatory ENS response
As expected, NF-κB p50/p65 heterodimer was detected in
the nuclear compartment at early phase of stimulation with
LPS (T30') (Figure 5A). Interestingly, the presence of p65
subunit was observed in all other experimental conditions
but not at T0 in BM suggesting that Wnt signaling inter-
fered with canonical NF-κB pathway [78]. Moreover, we
hypothesized that, due to alternative regulatory me-
chanisms, a possible specific stimulus-independent p65
translocation occurred [67,78]. In parallel, Co-IP assay
demonstrated that NF-кB p65 was present in the nucleus
both as free protein and β-catenin/p65 complex (Figure 5B).
As β-catenin showed a similar conformation pattern, our
data confirmed the hypothesis of a nuclear regulation of
Wnt signaling on LPS/NF-кB pathway [67]. Unlikely BM-
treated cultures, ENSc showed in SM an enhanced
Figure 4 WB analysis of Wnt/NF-κB interplay. A cross talk between TLR4 and Wnt signaling occurred as demonstrated by WB analysis at T0,
T30′, T1h, and T2h using specific antibodies for cytoplasmic p(Ser473)-Akt, p(Ser9)-GSK3β, p(Ser33)-β-catenin and nuclear β-catenin (n-β-catenin),
and NF-κB p65 (n NF-κB p65) in unstimulated cells; (A) samples treated with Wnt3a (20 ng/mL) (B) and LPS (5 μg/mL) (C) in SM and BM medium.
GAPDH and lamin B were considered as housekeeping proteins for the analysis of cytoplasmic and nuclear antigens. The quantification of protein
expression levels was performed using ImageJ processing software. Data were reported as ratio within target protein and relative housekeeping
protein expression. Statistical significance was calculated by Student’s t-test by comparing to control: p value ≤0.05*, p value ≤0.01**.
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free protein fraction.
Exogenous Wnt3a exerts anti-inflammatory activity on
ENSc
As suggested by RT-PCR (Figure 6B), a constitutive
expression of GDNF, EGF, basic fibroblast growth factor
(BFGF), NGF, and LIF was observed in all samples with-
out any significant modulation by culture conditions and
stimulation. These evidences highlighted that ENSc
might modulate their reactivity to exogenous Wnt3a
and LPS at longer time of culture (T7) through an en-
dogenous production of growth factors. For this reason,in our opinion, the specific effect of Wnt3a and LPS could
be really discriminated at early time of stimulation (T1). As
AXIN2, CJUN and CMYC are reported as target genes of β-
catenin transcriptional activity, their expression (p ≤ 0.01) at
T1 (Figure 6A) was considered dependent on the specific
activation of Wnt signaling in comparison to control. LPS
treatment enhanced (p ≤ 0.05) the gene expression of
FZD9 and WNT3A (p ≤ 0.01) while decreased (p ≤ 0.05)
the mRNA level of TLR4. Specific LPS-mediated response
showed an increased expression (p ≤ 0.05) of TNFa, IL6,
and IL1B genes while a reduced level (p ≤ 0.05) of IL10
mRNA was observed. The costimulation with LPS
and Wnt3a reversed the expression pattern of ENSc
Figure 5 WB and Co-IP of β-catenin and p65. (A) Wnt3a interfered with NF-κB p50/p65-mediated inflammatory response as suggested by WB
analysis of untreated Wnt3a (20 ng/mL) and/or LPS (5 μg/mL)-treated cells at T0, T30′, T1h, and T2h. The quantification of protein expression levels
was performed using the image processing software ImageJ. Data were reported as ratio within target protein and relative lamin B housekeeping
protein expression. Statistical significance was calculated by Student’s t-test comparing to control: p value ≤0.05*, p value ≤0.01**. (B) Co-IP assay
confirmed a nuclear interplay between Wnt signaling and LPS NF-кB pathway, as previously reported [67]. Immunoaffinity purification was carried
out using mouse anti-rat NF-κB p65 and mouse anti rat β-catenin antibodies pre-immobilized onto Protein A Sepharose.
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negative control (p ≤ 0.01) on the gene expression of pro-
inflammatory cytokines and to enhance ENS defense pro-
moting an increased expression of anti-inflammatory IL10
(p ≤ 0.01) and FZD9 (p ≤ 0.01). Probably due to a feedback
loop aimed to restore homeostatic conditions, TLR4
expression was increased by Wnt3a (p ≤ 0.05) (Figure 6A).
Discussion
When intestinal homeostasis [23] is disrupted by severe
inflammation, pathologic changes of ENS neurons [79-81]
and glial cells [82] occur, compromising gut motility andsecretion [73,82,83]. In concentration-dependent manner
[60], LPS contributes to ENS plasticity [84] and targets en-
teric neuronal and glial populations through TLR4 [85,86]
promoting the secretion of pro- and anti-inflammatory
effectors [87,88]. Recently, higher gene expression of
Wnt3a and FZD9 has been demonstrated in IBD disorders
in comparison to healthy patients [31] suggesting the in-
volvement of canonical Wnt signaling into gut inflamma-
tory response.
The current study identified rat FZD9 as a novel
marker associated with rat myenteric plexus and its
ability to respond to Wnt3a ligand activating β-catenin
Figure 6 Gene expression study on ENSc stimulated with Wnt3a and LPS. (A) The anti-inflammatory effect was demonstrated to be exerted
by Wnt3a using qPCR analysis and ENS cells treated with Wnt3a (20 ng/mL) and LPS (5 μg/mL). The analysis was focused on the expression of
β-catenin target genes (AXIN2, CMYC, and CJUN), membrane receptors (TLR4 and FZD9), Wnt3a ligand, and pro- and anti-inflammatory target
genes (IL1B, IL6, TNFa, and IL10). The amount of gene products was calculated using linear regression analysis from standard curves, demonstrating
the amplification efficiencies ranging from 90% to 100%. Data were reported as a fold increase of gene expression that is defined as the cDNA
ratio between target gene and reference gene (HPRT) normalized to untreated sample. Statistical significance was calculated using Student’s t-test,
comparing to untreated cells: p value ≤0.05*, p value ≤0.01**; samples compared to LPS-treated cells: p value ≤0.01 (two black triangles). (B) To
detect the gene expression of typical ENS growth factors (GDNF, EGF, BFGF, NGF, and LIF), RT-PCR was performed using Qiagen One Step RT-PCR
Kit on samples untreated (T0) and stimulated with Wnt3a (20 ng/mL) and LPS (5 μg/mL) for 1 (T1) and 7 (T7) days. RT-PCR products were
electrophoresed on 2% agarose gel and stained by GelRed™. HPRT was used as housekeeping gene.
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natal gut [90], the components of Wnt signaling are
expressed in complex spatial and temporal patterns
according to specific activities. Previous studies on
Frizzled 9 in human and mouse have shown that it is
highly expressed in the brain [21,91] and in neural pre-
cursor cells during developing nervous system [36,92].
Moreover, FZD9 protein has been localized at growth
cones of regenerating adult spiral ganglion neurons
[93] suggesting to be involved in neuronal response to
damage.As previously reported [71], the cultures of dissociated
postnatal gut give rise to multipotent ENS progenitors
generating in vitro neurons and glia. Based on FSC mor-
phological discrimination and positive reactivity to anti-
PAN neuronal marker by FCM analysis, the expression
of FZD9 was demonstrated to characterize the neuronal
compartment and to be preserved under BM and SM
culture conditions.
During ENS development, there is a critical balance
among migration, survival, proliferation, and differen-
tiation of neural crest cells (NCCs). A fine control of
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NCCs enter the foregut at the correct time while proli-
feration and differentiation are maintained at a balanced
level at migration wavefront. It is known that the micro-
environment plays a pivotal role to regulate the extent of
ENS formation influencing on NCC number and gut
colonization. Although neurotrophic factors are demon-
strated to be essential for gut formation, the biological
processes controlled by these factors are not yet com-
pletely elucidated [94,95]. In both BM and SM, a stem
cell subset including enteric nervous stem cells (ENSCs)
[96,97] is maintained during in vitro culturing. Nu-
merous evidences suggest that germinal niches are adja-
cent to myenteric ganglia, and myenteric plexus-derived
preparations are enriched of ENSCs. Using genetic fate
mapping of Sox10, a neural crest cell marker [98], it has
demonstrated that in postnatal gut, Sox10 positive cells
can act as neuroprogenitor cells and regenerate neurons
after damage. CD34 has been demonstrated to be ex-
pressed in hematopoietic stem cells [99,100], putative
endothelial cells [101], and mesenchymal precursor cells
[102]. In the gut, CD34 expression has been reported
either in interstitial Cajal cells together with cKit, CD44
[103], and ENSC [104] that, likely committed lineage
cells [71,105-108], are commonly characterized by p75
[104,105] and Sox2 [106,109]. In our study, as previously
shown by Hagl et al. [47], the expression of Nanog con-
firmed the existence of stem cells with high differentia-
tive potentiality and the absence of cKit and CD44 led to
consider CD34 as associated to an immature cell popu-
lation rather than interstitial Cajal cells.
As suggested by the expression level of Sox10, p75,
and GFAP, glial cells were stimulated under standard
culture conditions while neuronal committed cells ex-
pressing Sox2, NG2 [110,111], and PAN neuronal mar-
ker were in vitro maintained and numerically increased
when deprived of bFGF, EGF, GDNF, and NGF. These
evidences suggested that a diminished availability of
neurotrophic factors fostered neuronal commitment of
progenitors but negatively controlled the cell differen-
tiation process as shown by lacking neurosphere forma-
tion. In contrast, under standard culture conditions, glial
differentiation was promoted more than neuronal and
neurospheres were regularly formed.
Under Wnt3a (20 ng/mL) and LPS (5 μg/mL) stimu-
lation, neurospheres were demonstrated to increase in
number and size. After 1 day of culture, the neurosphere
diameter was 10 μm bigger in LPS- and Wnt3a-treated
samples than that observed in control. At T7, the num-
ber of neurospheres was doubled in LPS-treated samples
compared to that detected under Wnt3a stimulation.
Interestingly, a larger diameter of neurospheres was
induced by Wnt3a with respect to LPS. The different
proliferation effect could be indicative of a protectivemechanism that, through the stimulation of immature
cells but by the activation of different pathways, LPS
[44] and Wnt3a [112] guaranteed a neural renewal.
Although FZD9 in human has been shown to bind
Drosophila Wingless [91], the first evidence of its ability
to activate Wnt/β-catenin signaling through the binding
of Wnt2 ligand was obtained from Karasawa et al. [37]
by an in vitro rat model.
The interaction between Wnts and Frizzled receptors
is specific and differently involved in physiological and
pathological conditions [3,113]. In our case, the demon-
strated ability of FZD9 to bind Wnt3a and the presence
of Wnt3a in glial cells provided the evidence of a pos-
sible protective role exerted by glia on enteric neurons
through the activation of Wnt canonical pathway at
physiological state or pathological conditions [114].
Wnt1 and Wnt3a are coexpressed at the dorsal midline
of the developing neural tube and control the midbrain
patterning and the formation of the paraxial mesoderm,
respectively. When a deficiency of both Wnt1 and Wnt3a
is observed, the development of neural crest derivatives is
compromised suggesting that local Wnt signaling regu-
lates the expansion of dorsal neural precursors. Despite
the high number of mammalian Wnt and Frizzled mem-
bers, a poor characterization of Wnt Frizzled binding
specificities is reported.
In particular, it is known that canonical Wnt signaling
controls crypt progenitor gene expression pattern [115].
Recently, several studies have implied the involvement
of canonical Wnt Frizzled signaling in inflammatory
bowel disease (IBD) [21,31], as a significant increased
expression of Wnt3a and Frizzled receptors are observed
[114]. In the current study, the nuclear translocation of
β-catenin in rat ENS cells under stimulation with ex-
ogenous Wnt3a suggested that canonical Wnt pathway
is active in postnatal myenteric plexus and Frizzled 9
could be involved as a specific ligand. The trans-
criptional regulation of FZD9 after the treatment with
Wnt3a suggested that it might play a role in the context
of inflammation. Only little is known about the expres-
sion and function of FZD9 in postnatal ENS. Among
frizzled receptors, we demonstrated that FZD9 protein
was significantly expressed on freshly extracted ENS
cells and maintained in ex vivo cultured neuronal popu-
lation. As previously reported [94], the regulation by
Wnt signaling could be interpreted as protective and
might be involved in the ENS defense. Activated Wnt3a/
β-catenin signaling pathway is known to stimulate intes-
tinal epithelial repair after wounding [116] and neural
restricted precursor cell populations [117]. In our study,
the binding specificity of Frizzled 9 with Wnt3a was
demonstrated in ENS compartment and suggested the
involvement of FZD9 in neuronal response to inflamma-
tion in light of the evidence that a significant increase of
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diseases [31]. The expression of TLR4 by the enteric
neural cells highlighted the presence of a neural sur-
veillance network that activates a cell-specific response
against bacterial agents when the epithelial barrier per-
meability is altered [86]. In the present study, the ex-
pression of both TLR4 and Frizzled 9 was detected in
the neuronal population, while glial cells were charac-
terized only by TLR4. Our evidences suggested that a
neuronal subset was responsive to inflammatory agents
through TLR-based mechanism and was regulated by
Frizzled 9-mediated canonical Wnt signaling.
The cross regulation of Wnt and NF-кB signaling path-
ways has been shown to modify the biological effects of
gene expression during development, immune function,
inflammation, and carcinogenesis. A wide spectrum of
phosphorylation/acetylation events and associating pro-
teins is demonstrated to modulate the activation or inhib-
ition of β-catenin, NF-кB, or their binding activity to DNA
[67], independently on specific stimuli. In the last two de-
cades, a lot of experimental data have reported that the
interplay between Wnt signaling and NF-кB is expressed
at different levels and is subject to variations in depen-
dence of PI3K/Akt pathway, cell type specificity, and
physiological/pathological conditions [118].
In the present work, we have demonstrated that ca-
nonical Wnt signaling is active in ENS and cross talks
with NF-кB modulating the response to LPS. Phosphor-
ylation events at serine 473 activate Akt and lock it at
active conformation [119]. In both standard and basal
medium, the presence of nuclear β-catenin and NF-кB
was observed in the absence of exogenous stimulation
with Wnt3a and LPS and thus was correlated with active
p(Ser473)-Akt.
As p(Ser9)-GSK3β was detected only in standard
medium and p(Ser33)-β-catenin started to be expressed
at T1h, we hypothesized that Akt controls phospho-
rylation events in resting cells promoting directly or in-
directly both activation and degradation of β-catenin,
besides nuclear translocation of NF-кB p65. It was dem-
onstrated that Akt phosphorylates β-catenin at Ser552
leading first to its dissociation from cell-cell contacts
and then to the increase of its binding to 14 3 3 proteins
and its transcriptional activity [120]. As GSK3β is active
in resting cells and is inactivated through serine 9 phos-
phorylation induced by mitogens, growth factors, and
several kinases, including Akt [121], we hypothesized
that endogenous factors could contribute to regulated
activation of Akt and control the stabilization of β-
catenin by IKKα [65,67]. Wnt- and FGF-dependent PI3K
Akt signaling pathways cross talk during a variety of cel-
lular processes including neurogenesis [122] and both
lead to GSK3β downregulation although depending on
different phosphorylation events. In contrast to FGFsignaling, the canonical Wnt is reported to be independ-
ent on Ser 9 phosphorylation. In the present work, we
demonstrated that Wnt3a and LPS cross talk at the level
of GSK3β and deactivate it by Ser9 phosphorylation,
even if other phosphorylation events are not excluded
because our in vitro model is not based on the inhibition
of PI3K/Akt signaling pathway but only on the de-
privation of main ENS trophic factors. This activity is
hypothesized to be specifically dependent on the activa-
tion of Wnt and NF-кB signaling, probably modulated
by GSK3β but not depending on exogenous growth fac-
tors such as bFGF and EGF as the evidences were taken
from basal medium-treated samples. The concomitant
presence of p(Ser33)-β-catenin and p(Ser9) GSK3β at
early phase of Wnt3a and LPS stimulation suggested
that alternative mechanisms of phosphorylation might
occur promoting the negative control of β-catenin and
thus its modulation. As the protein expression profile
detected in standard and basal medium-treated samples
showed a stronger accumulation of β-catenin at late
phase of Wnt3a stimulation, GSK3β downregulation by
simultaneous treatment with Wnt and growth factors is
hypothesized to involve GSK3β pools differently modu-
lated by Akt.
The critical role of Akt signaling for neuroprotection
against deprivation of growth factors [123], oxidative
stress [124], and ischemic injury [125] is evidenced from
several in vitro studies on neuronal cell lines or primary
cultures. Phosphorylation of Akt through phosphati-
dylinositol 3 kinase is essential to promote ENS precur-
sor survival [8]. Akt level expression was correlated with
a constitutive activation of a neuroprotective mechanism
as previously reported by Humbert et al. [126]. Inte-
restingly, in basal medium-treated samples, LPS re-
sponse evidenced a superior expression level of nuclear
β-catenin than that observed in ENS cells cultured in
standard medium probably due to an interaction of Akt
with GSK3β [127]. As BM-based in vitro model could
simulate pathological conditions, wherein the limited or
absent supply of growth factors promotes gut inflamma-
tion, the higher nuclear translocation of β-catenin could
be interpreted as a negative regulation of NF-кB p65
transcriptional activity.
As GSK3β has been shown to regulate NF-кB at the
level of transcriptional complex [128] and β-catenin is
a major substrate of GSK3β, it is hypothesized that
β-catenin might serve as a mediator for the cross regula-
tion between Wnt and NF-кB signaling pathways at dif-
ferent levels and cellular compartments (Figure 7). The
binding of β-catenin and NF-кB on specific regions of
DNA is suggested to be fine regulated, as the activation and
nuclear translocation of both transcription factors might be
promoted without any specific stimulated signaling path-
way, but only due to a cascade of phosphorylation events.
Figure 7 The interplay model of Wnt/β-catenin, LPS/TLR4, and growth factors in ENS. After the interaction of Wnt ligands with a G protein-
coupled receptor (Frizzled), GSK3β is inhibited and β-catenin is released from a “scaffolding” complex consisting of Axin, adenomatous polyposis
coli (APC), casein kinase 1 (CK1), and glycogen synthase kinase 3β (GSK3β). Consequently, the stabilized β-catenin shuttles to the nucleus and the
transcription process of its target genes is promoted. LPS-mediated activation of TLR4 pathway or growth factor signaling involves phosphatidylinositol
3 kinase (PI3K) pathway. PI3K inactivates GSK3β through Akt, and nuclear accumulation of β-catenin occurs. In steady conditions, β-catenin is trapped
at the plasma membrane by cadherins or is tagged by phosphorylation for ubiquitin-mediated degradation. In parallel, PI3K and TRAF6 inhibit IκBα
and the activated heterodimer NF-κB p50/p65 translocates to the nucleus for promoting the specific gene expression.
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monstrated that nuclear β-catenin and NF-кB p65 could
complex together or are present as free proteins in rest-
ing ENS cells. The β-catenin/p65 complex and the free
proteins resulted to be differently expressed in depend-
ence on experimental conditions. It is already reportedthat β-catenin can physically interact with p65 and p50
subunits to inhibit the binding of NF-кB to DNA
in IкBα-independent manner and in association with
additional cellular factors [78]. Interestingly, suppressed
NF-кB activity and target gene expression were observed
in cells expressing high level of β-catenin [78]. Hwang
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binding of p65 and β-catenin showing that the spe-
cific transcriptional activity of β-catenin is regulated by
protein-protein interaction with p65 at transcriptional
level of their target genes. As the promoters of Wnt sig-
naling target genes contain NF-кB binding elements, in
the absence of specific stimulation, a constitutive bind-
ing of β-catenin/p65 complex to NF-кB sites is suggested
to block β-catenin transcriptional activity. After Wnt sig-
naling activation, the nuclear accumulation of β-catenin
leads to the displacement of p65 from gene promoters
and to the binding of β-catenin TCF transcriptional
complex to DNA. Under LPS activation, IKKα-mediated
phosphorylation of nuclear p65 subunit within the trans-
activation domains promotes the transient transcrip-
tional activity of NF-кB target genes [67].
The major expression of β-catenin/NF-кB p65 com-
plex in SM-treated samples was correlated to the greater
accumulation of nuclear β-catenin and NF-кB p65 deri-
ving from aspecific stimulation of NF-kB (or alternative
NF-кB pathway) and Wnt signaling pathway exerted by
trophic factors [127]. Only the stimulation with LPS re-
sulted into the activation of canonical NF-кB pathway, as
demonstrated by the nuclear presence of NF-кB p50/p65.
This evidence confirmed that a large diversity of signals
might converge on degradation of IкBs, the known pro-
teins that physically mask the nuclear localization signal
(NLS) of NF-кB p65. However, the DNA binding activity
of NF-кB to IкB sites, among a large excess of potential
binding sites, is specifically controlled by NF-кB subunits,
associated proteins, and binding to nuclear chromatin.
The specific responsiveness of ENS cells to Wnt3a or
LPS stimulation was confirmed evaluating the transcrip-
tional activity of nuclear β-catenin and p65 subunit in
samples cultured in basal medium. Both canonical Wnt
signaling and NF-кB pathway are expressed in ENS and
control gut homeostasis [129]. As the FZD9 expression
was observed only in neuronal subpopulation while that
of TLR4 resulted on both neurons and glial cells, we
asked us which reciprocal regulation occurs between ca-
nonical Wnt pathway and NF-кB signaling in ENS neu-
rons at physiological and inflamed conditions. The high
level of GSK3β expression in brain tissue is likely due to
its essential role in neuronal signaling. In neuronal cells,
it is required for dendrite extension and synapse forma-
tion in newborns. Dysregulation of GSK3β expression
leads to many pathological conditions, including neur-
onal dysfunction, Alzheimer’s disease [130], and Parkin-
son’s disease [131]. Highly expressed in colorectal cancer
[132,133], it has been shown to participate in NF-кB-
mediated cell survival in pancreatic cancer [134]. In cell
culture studies, apoptosis is attenuated or fully abrogated
by the inhibition of GSK3β in primary neurons [135]
and neuronal cell lines [136]. The Wnt pathway isinvolved in regulation of gut homeostasis. Under intes-
tinal inflammation, the expression level of Wnt3a signifi-
cantly increases [31] and neuronal apoptosis is observed
[60].
Schaale et al. [137] described a regulatory role of Wnt
signaling in inflammatory processes and reported that
exogenous Wnt3a mediates anti-inflammatory effects in
macrophages promoting the suppression of proinflamma-
tory cytokines. Moreover, Li et al. demonstrated that Wnt
signaling contributes to Alzheimer’s disease-related neuro-
degeneration by regulating neuroinflammation [138] and
plays a crucial role in the expression of proinflammatory
cytokines in the central nervous system [139]. In our
study, LPS treatment enhanced the gene expression of
FZD9 and Wnt3a but reduced the level of TLR4 mRNA,
suggesting a possible negative feedback scenario in which
a positive regulation of Wnt pathway could be exerted by
NF-кB signaling to restore homeostatic conditions. This
hypothesis was further confirmed evaluating that the spe-
cific LPS-mediated inflammatory response was reversed in
the presence of Wnt3a as demonstrated by a reduced ex-
pression of TNFa, IL6, and IL1B genes and, interestingly,
an increased level of IL10 mRNA. As it is reported that
LPS-treated enteric neurons respond stimulating the se-
cretion of inflammatory cytokines such as IL6, TNFa [129]
to activate glial cells that, in turn, release IL1B, the inhibi-
tory activity exerted by Wnt3a could be interpreted as
effective to control glial activation.
Taken together these considerations, we concluded
that Wnt3a exerts a negative control of NF-кB transcrip-
tional activity in rat myenteric plexus and contributes to
ENS defense by the stimulation of IL10, TLR4, and
FZD9 expression. In turn, LPS balances the inflamma-
tory response stimulating Wnt signaling and enhancing
the transcription level of FZD9 and Wnt3a.Conclusions
The results of this study suggested the existence of neu-
ronal surveillance through FZD9 and Wnt3a in enteric
myenteric plexus. As detected in freshly isolated ENS
cells, FZD9 was hypothesized to be expressed in constitu-
tive manner for some homeostatic activities. Although the
total number of FZD9 positive cells cultured under stan-
dard and basal conditions did not significantly change, the
expression level of FZD9 was upregulated in response to
GDNF, bFGF, and NGF, suggesting a possible involvement
of Wnt signaling in neuronal and glial differentiation.
Interestingly, under in vitro-simulated inflammation, Wnt
signaling was demonstrated to exert an anti-inflammatory
activity to negatively control NF-кB pathway.Competing interests
The authors declare that they have no competing interest.
Di Liddo et al. Journal of Neuroinflammation  (2015) 12:23 Page 17 of 19Authors’ contributions
RDL and TB designed and performed the research, analyzed and interpreted
the data, and wrote the manuscript. AS performed the research and
analyzed the data. SS, AT, and IZ performed the research. MTC and KHS
made the conception and design of experiments, performed the data
analysis and interpretation, and did the final approval of the manuscript.
All authors read and approved the final manuscript.Acknowledgments
Padua University (Grant ex60% Project) supported this work. We thank Prof.
Pier Paolo Parnigotto and the Italian Association of Blood Donors (AVIS) of
Veneto Region that contributed to acquire instrumental equipment
(FACSCanto II cytometer). A special thanks to Silvia Barbon, Senthilkumar
Rajendran, and Riccardo Sfriso for technical assistance.
Author details
1Department of Pharmaceutical and Pharmacological Sciences, University of
Padova, Via Marzolo 5, 35131 Padova, Italy. 2Department of Biotechnology,
University of Applied Sciences Kaiserslautern, Zweibrücken, Germany.
Received: 15 October 2014 Accepted: 14 January 2015
References
1. De Santa Barbara P, Van den Brink GR, Roberts DJ. Development and
differentiation of the intestinal epithelium. Cell Mol Life Sci. 2003;60(7):1322–32.
2. Stuhlmiller TJ, García Castro MI. Current perspectives of the signalling pathways
directing neural crest induction. Cell Mol Life Sci. 2012;69(22):3715–37.
3. Gregorieff A, Pinto D, Begthel H, Destrée O, Kielman M, Clevers H.
Expression pattern of Wnt signaling components in the adult intestine.
Gastroenterology. 2005;129(2):626–38.
4. Wodarz A, Nusse R. Mechanisms of Wnt signalling in development. Annu
Rev Cell Dev Biol. 1998;14:59–88.
5. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, et al. A new
member of the frizzled family from Drosophila functions as a wingless
receptor. Nature. 1996;382(6588):225–30.
6. Katoh M. Cross talk of WNT and FGF signalling pathways at GSK3beta to
regulate beta catenin and SNAIL signalling cascades. Cancer Biol Ther.
2006;5(9):1059–64.
7. Ojeda L, Gao J, Hooten KG, Wang E, Thonhoff JR, Dunn TJ, et al. Critical role
of PI3K/Akt/GSK3β in motoneuron specification from human neural stem
cells in response to FGF2 and EGF. PLoS One. 2011;6(8):e23414.
8. Srinivasan S, Anitha M, Mwangi S, Heuckeroth RO. Enteric neuroblasts
require the phosphatidylinositol 3 kinase/Akt/forkhead pathway for GDNF
stimulated survival. Mol Cell Neurosci. 2005;29(1):107–19.
9. Higuchi M, Onishi K, Masuyama N, Gotoh Y. The phosphatidylinositol 3
kinase (PI3K) Akt pathway suppresses neurite branch formation in NGF
treated PC12 cells. Genes Cells. 2003;8(8):657–69.
10. Clevers H, Nusse R. Wnt/β catenin signalling and disease. Cell.
2012;149(6):1192–205.
11. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL, et al.
Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad
Sci U S A. 2008;105(44):16970–5.
12. Polakis P. Wnt signalling and cancer. Genes Dev. 2000;14(15):1837–51.
13. Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright NA. Role of intestinal
subepithelial myofibroblasts in inflammation and regenerative response in
the gut. Pharmacol Ther. 2007;114(1):94–106.
14. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A,
et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor
phenotype on colorectal cancer cells. Cell. 2002;111(2):241–50.
15. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al.
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium
by controlling the expression of EphB/ephrinB. Cell. 2002;111(2):251–63.
16. Logan CY, Nusse R. The Wnt signalling pathway in development and
disease. Annu Rev Cell Dev Biol. 2004;20:781–810.
17. You XJ, Bryant PJ, Jurnak F, Holcombe RF. Expression of Wnt pathway
components Frizzled and Disheveled in colon cancer arising in patients
with inflammatory bowel disease. Oncol Rep. 2007;18(3):691–4.
18. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, et al. Crosstalk
between NF-kappaB and beta-catenin pathways in bacterial-colonizedintestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol.
2005;289(1):G129–37.
19. Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, et al.
Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is
involved in reprogramming Mycobacterium tuberculosis-infected
macrophages. FASEB J. 2010;24(11):4599–612.
20. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang
YC, et al. Activation of beta-catenin in dendritic cells regulates immunity
versus tolerance in the intestine. Science. 2010;329(5993):849–53.
21. Sen M, Ghosh G. Transcriptional outcome of Wnt Frizzled signal
transduction in inflammation: evolving concepts. J Immunol.
2008;181(7):4441–5.
22. Cadigan KM, Nusse R. Wnt signalling: a common theme in animal
development. Genes Dev. 1997;11(24):3286–305.
23. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior
during vertebrate development. Trends Genet. 1997;13(4):157–62.
24. Kühl M, Sheldahl LC, Park M, Miller JR, Moon RT. The Wnt/Ca2+ pathway:
a new vertebrate Wnt signalling pathway takes shape. Trends Genet.
2000;16(7):279–83.
25. Parr BA, Shea MJ, Vassileva G, McMahon AP. Mouse Wnt genes exhibit
discrete domains of expression in the early embryonic CNS and limb buds.
Development. 1993;119(1):247–61.
26. de Lau W, Barker N, Clevers H. WNT signalling in the normal intestine and
colorectal cancer. Front Biosci. 2007;12:471–91.
27. Pinto D, Clevers H. Wnt control of stem cells and differentiation in the
intestinal epithelium. Exp Cell Res. 2005;306(2):357–63.
28. Kawaguchi J, Nichols J, Gierl MS, Faial T, Smith A. Isolation and propagation
of enteric neural crest progenitor cells from mouse embryonic stem cells
and embryos. Development. 2010;137(5):693–704.
29. Koch S, Nava P, Addis C, Kim W, Denning TL, Li L, et al. The Wnt antagonist
Dkk1 regulates intestinal epithelial homeostasis and wound repair.
Gastroenterology. 2011;141(1):259–68. 268.e1 8.
30. Sokol SY. Maintaining embryonic stem cell pluripotency with Wnt signalling.
Development. 2011;138(20):4341–50.
31. You J, Nguyen AV, Albers CG, Lin F, Holcombe RF. Wnt pathway
related gene expression in inflammatory bowel disease. Dig Dis Sci.
2008;53(4):1013–9.
32. Rulifson EJ, Wu CH, Nusse R. Pathway specificity by the bifunctional
receptor frizzled is determined by affinity for wingless. Mol Cell.
2000;6(1):117–26.
33. Wu CH, Nusse R. Ligand receptor interactions in the Wnt signalling pathway
in Drosophila. J Biol Chem. 2002;277(44):41762–9.
34. Takada R, Hijikata H, Kondoh H, Takada S. Analysis of combinatorial effects
of Wnts and Frizzleds on beta catenin/armadillo stabilization and
Dishevelled phosphorylation. Genes Cells. 2005;10(9):919–28.
35. Wang YK, Spörle R, Paperna T, Schughart K, Francke U. Characterization
and expression pattern of the Frizzled gene Fzd9, the mouse homolog
of FZD9 which is deleted in Williams Beuren syndrome. Genomics.
1999;57(2):235–48.
36. Van Raay TJ, Wang YK, Stark MR, Rasmussen JT, Francke U, Vetter ML, et al.
Frizzled 9 is expressed in neural precursor cells in the developing neural
tube. Dev Genes Evol. 2001;211(8 9):453–7.
37. Karasawa T, Yokokura H, Kitajewski J, Lombroso PJ. Frizzled 9 is activated
by Wnt 2 and functions in Wnt/beta catenin signalling. J Biol Chem.
2002;277(40):37479–86.
38. Cai J, Wu Y, Mirua T, Pierce JL, Lucero MT, Albertine KH, et al. Properties of a
fetal multipotent neural stem cell (NEP cell). Dev Biol. 2002;251(2):221–40.
39. Schäfer KH, Mestres P. The GDNF induced neurite outgrowth and neuronal
survival in dissociated myenteric plexus cultures of the rat small intestine
decreases postnatally. Exp Brain Res. 1999;125:447–52.
40. Friedman WJ, Greene LA. Neurotrophin signalling via Trks and p75. Exp Cell
Res. 1999;253:131–42.
41. Chadi G, Gomide VC, Rodrigues de Souza R, Scabello RT, Maurício da Silva
C. Basic fibroblast growth factor, neurofilament, and glial fibrillary acidic
protein immunoreactivities in the myenteric plexus of the rat esophagus
and colon. J Morphol. 2004;261(3):323–33.
42. McLeay LM, Comeskey MA, Waters MJ. Effects of epidermal growth factor
on gastrointestinal electromyographic activity of conscious sheep.
J Endocrinol. 1990;124:109–15.
43. Chalazonitis A, Rothman TP, Chen J, Vinson EN, MacLennan AJ, Gershon
MD. Promotion of the development of enteric neurons and glia by
Di Liddo et al. Journal of Neuroinflammation  (2015) 12:23 Page 18 of 19neuropoietic cytokines: interactions with neurotrophin 3. Dev Biol.
1998;198:343–65.
44. Schuster A, Klotz M, Schwab T, Di Liddo R, Bertalot T, Schrenk S, et al.
Maintenance of the enteric stem cell niche by bacterial lipopolysaccharides?
Evidence and perspectives. J Cell Mol Med. 2014;18(7):1429–43.
45. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M. Renal and neuronal
abnormalities in mice lacking GDNF. Nature. 1996;382:76–9.
46. Kuroda T, Ueda M, Nakano M, Saeki M. Altered production of nerve growth factor
in aganglionic intestines. J Pediatr Surg. 1994;29(2):288–92. discussion 292 3.
47. Hagl CI, Heumüller Klug S, Wink E, Wessel L, Schäfer KH. The human
gastrointestinal tract, a potential autologous neural stem cell source. PLoS
One. 2013;8(9):e72948.
48. Wester T, Olsen L. Expression of leukaemia inhibitory factor during the
development of the human enteric nervous system. Histochem J.
2000;32(6):345–8.
49. Rusmini M, Griseri P, Lantieri F, Matera I, Hudspeth KL, Roberto A, et al.
Induction of RET dependent and independent pro-inflammatory programs
in human peripheral blood mononuclear cells from Hirschsprung patients.
PLoS One. 2013;8(3):e59066.
50. Ding VM, Ling L, Natarajan S, Yap MG, Cool SM, Choo AB. FGF-2 modulates
Wnt signaling in undifferentiated hESC and iPS cells through activated
PI3-K/GSK3beta signaling. J Cell Physiol. 2010;225(2):417–28.
51. Mwangi S, Anitha M, Fu H, Sitaraman SV, Srinivasan S. Glial cell line derived
neurotrophic factor mediated enteric neuronal survival involves glycogen
synthase kinase 3beta phosphorylation and coupling with 14 3 3.
Neuroscience. 2006;143(1):241–51.
52. Frykman PK, Short SS. Hirschsprung associated enterocolitis: prevention and
therapy. Semin Pediatr Surg. 2012;21(4):328–35.
53. Cirillo C, Sarnelli G, Turco F, Mango A, Grosso M, Aprea G, et al. Proinflammatory
stimuli activates human-derived enteroglial cells and induces autocrine nitric
oxide production. Neurogastroenterol Motil. 2011;23(9):e372–82.
54. Dodd PR. Excited to death: different ways to lose your neurones.
Biogerontology. 2002;3(1 2):51–6.
55. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, et al.
Toll-like receptor 4 imparts ligand-specific recognition of bacterial
lipopolysaccharide. J Clin Invest. 2000;105(4):497–504.
56. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll like
receptor 4 mediates lipopolysaccharide induced signal transduction. J Biol
Chem. 1999;274:10689–92.
57. Cario E, Podolsky DK. Intestinal epithelial TOLLerance versus inTOLLerance
of commensals. Mol Immunol. 2005;42(8):887–93. 23.
58. Medert R, Schuster A, Schwarz LK, Schwab T, Schaefer KH. Spiking rate of
myenteric neurons recorded from multi electrode arrays depending on
local microenvironment. Phys Status Solidi C. 2013;10(5):877–81.
59. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage
activation and deactivation by LPS. Microbes Infect. 2002;4:903–14.
60. Arciszewski M, Pierzynowski S, Ekblad E. Lipopolysaccharide induces
cell death in cultured porcine myenteric neurons. Dig Dis Sci.
2005;50(9):1661–8.
61. Okun E, Griffioen KJ, Mattson MP. Toll like receptor signalling in neural
plasticity and disease. Trends Neurosci. 2011;34:269–81.
62. Monick MM, Carter AB, Robeff PK, Flaherty DM, Peterson MW, Hunninghake
GW. Lipopolysaccharide activates Akt in human alveolar macrophages
resulting in nuclear accumulation and transcriptional activity of beta-catenin.
J Immunol. 2001;166(7):4713–20.
63. Arciszewski MB, Sand E, Ekblad E. Vasoactive intestinal peptide rescues
cultured rat myenteric neurons from lipopolysaccharide induced cell death.
Regul Pept. 2008;146(1 3):218–23.
64. He Z, Gao Y, Deng Y, Li W, Chen Y, Xing S, et al. Lipopolysaccharide induces
lung fibroblast proliferation through toll-like receptor 4 signaling and the
phosphoinositide3-kinase-Akt pathway. PLoS One. 2012;7(4):e35926.
65. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, et al.
Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem.
2001;276(45):42276–86.
66. Häcker H, Karin M. Regulation and function of IKK and IKK related kinases.
Sci STKE. 2006;2006(357):re13.
67. Wan F, Lenardo MJ. Specification of DNA binding activity of NF kappaB
proteins. Cold Spring Harb Perspect Biol. 2009;1(4):a000067.
68. Nusse R. Wnt signalling and stem cell control. Cell Res. 2008;18:523–7.
69. Katoh M. WNT signalling pathway and stem cell signalling network. Clin
Cancer Res. 2007;13:4042–5.70. Kleber M, Sommer L. Wnt signalling and the regulation of stem cell
function. Curr Opin Cell Biol. 2004;16:681–7.
71. Vasina V, Barbara G, Talamonti L, Stanghellini V, Corinaldesi R, Tonini M,
et al. Enteric neuroplasticity evoked by inflammation. Auton Neurosci.
2006;126–127:264–72.
72. Bondurand N, Natarajan D, Thapar N, Atkins C, Pachnis V. Neuron and glia
generating progenitors of the mammalian enteric nervous system isolated
from foetal and postnatal gut cultures. Development. 2003;130:6387–400.
73. Wood JD. Enteric neuroimmunophysiology and pathophysiology.
Gastroenterology. 2004;127:635–57.
74. Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S. Wnt signalling
required for expansion of neural crest and CNS progenitors. Nature.
1997;389:966–70.
75. Verzi MP, Shivdasani RA. Wnt signalling in gut organogenesis.
Organogenesis. 2008;4(2):87–91.
76. Schäfer KH, Saffrey MJ, Burnstock G, Mestres VP. A new method for the
isolation of myenteric plexus from the newborn rat gastrointestinal tract.
Brain Res Brain Res Protoc. 1997;1(2):109–13.
77. Bonifacino JS, Dell’Angelica EC. Immunoprecipitation. Curr Protoc Cell Biol.
2001;Chapter 7:Unit 7.2.
78. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, et al. Beta-catenin
interacts with and inhibits NF-kappa B in human colon and breast cancer.
Cancer Cell. 2002;2(4):323–34.
79. Storsteen KA, Kernohan JW, Bargen JA. The myenteric plexus in chronic
ulcerative colitis. Surg Gynecol Obstet. 1953;97(3):335–43.
80. Davis DR, Dockerty MB, Mayo CW. The myenteric plexus in regional
enteritis: a study of the number of ganglion cells in the ileum in 24 cases.
Surg Gynecol Obstet. 1955;101(2):208–16.
81. Dvorak AM, Monahan RA, Osage JE, Dickersin GR. Crohn’s disease:
transmission electron microscopic studies. II. Immunologic inflammatory
response: alterations of mast cells, basophils, eosinophils, and the
microvasculature. Hum Pathol. 1980;11(6):606–19.
82. Villanacci V, Bassotti G, Nascimbeni R, Antonelli E, Cadei M, Fisogni S, et al.
Enteric nervous system abnormalities in inflammatory bowel diseases.
Neurogastroenterol Motil. 2008;20(9):1009–16.
83. Lomax AE, Fernandez E, Sharkey KA. Plasticity of the enteric nervous system
during intestinal inflammation. Neurogastroenterol Motil. 2005;17:4–15.
84. Schäfer KH, Van Ginneken C, Copray S. Plasticity and neural stem cells in the
enteric nervous system. Anat Rec (Hoboken). 2009;292:1940–52.
85. Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S, et al.
Activation of smooth muscle and myenteric plexus cells of jejunum via
toll-like receptor 4. J Cell Physiol. 2006;208(1):47–54.
86. Barajon I, Serrao G, Arnaboldi F, Opizzi E, Ripamonti G, Balsari A, et al.
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system
and dorsal root ganglia. J Histochem Cytochem. 2009;57(11):1013–23.
87. Metzger M, Caldwell C, Barlow AJ, Burns AJ, Thapar N. Enteric nervous
system stem cells derived from human gut mucosa for the treatment of
aganglionic gut disorders. Gastroenterology. 2009;136:2214–25. e1–3.
88. Ruhl A. Glial cells in the gut. Neurogastroenterol Motil. 2005;17:777–90.
89. Na T, Tabin CJ. Wnt signalling during development of the gastrointestinal
tract. Dev Biol. 2003;259:258–71.
90. Leedham SJ, Rodenas-Cuadrado P, Howarth K, Lewis A, Mallappa S,
Segditsas S, et al. A basal gradient of Wnt and stem-cell number influences
regional tumour distribution in human and mouse intestinal tracts. Gut.
2013;62(1):83–93.
91. Wang YK, Samos CH, Peoples R, Pérez-Jurado LA, Nusse R, Francke U. A
novel human homologue of the Drosophila Frizzled Wnt receptor gene
binds wingless protein and is in the Williams syndrome deletion at 7q11.23.
Hum Mol Genet. 1997;6(3):465–72.
92. Chang CH, Tsai RK, Tsai MH, Lin YH, Hirobe T. The roles of Frizzled 3 and
Wnt3a on melanocyte development: in vitro studies on neural crest cells
and melanocyte precursor cell lines. J Dermatol Sci. 2014;75(2):100–8.
93. Shah SM, Kang YJ, Christensen BL, Feng AS, Kollmar R. Expression of Wnt
receptors in adult spiral ganglion neurons: Frizzled 9 localization at growth
cones of regenerating neurites. Neuroscience. 2009;164(2):478–87.
94. Gianino S, Grider JR, Cresswell J, Enomoto H, Heuckeroth RO. GDNF
availability determines enteric neuron number by controlling precursor
proliferation. Development. 2003;130(10):2187–98.
95. Becker L, Kulkarni S, Tiwari G, Micci MA, Pasricha PJ. Divergent fate and
origin of neurosphere like bodies from different layers of the gut. Am J
Physiol Gastrointest Liver Physiol. 2012;302(9):G958–65.
Di Liddo et al. Journal of Neuroinflammation  (2015) 12:23 Page 19 of 1996. Rauch U, Hänsgen A, Hagl C, Holland Cunz S, Schäfer KH. Isolation and
cultivation of neuronal precursor cells from the developing human enteric
nervous system as a tool for cell therapy in dysganglionosis. Int J Colorectal
Dis. 2006;21(6):554–9.
97. Almond S, Lindley RM, Kenny SE, Connell MG, Edgar DH. Characterisation
and transplantation of enteric nervous system progenitor cells. Gut.
2007;56(4):489–96.
98. Laranjeira C, Sandgren K, Kessaris N, Richardson W, Potocnik A, Vanden
Berghe P, et al. Glial cells in the mouse enteric nervous system can undergo
neurogenesis in response to injury. J Clin Invest. 2011;121(9):3412–24.
99. Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, et al. Isolation
and characterization of human bone marrow microvascular endothelial cells:
hematopoietic progenitor cell adhesion. Blood. 1994;84(1):10–9.
100. Holyoake TL, Alcorn MJ. CD34+ positive haemopoietic cells: biology and
clinical applications. Blood Rev. 1994;8:113–24.
101. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al.
Isolation of putative progenitor endothelial cells for angiogenesis. Science.
1997;275(5302):964–7.
102. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger
JA, et al. Mesenchymal precursor cells in the blood of normal individuals.
Arthritis Res. 2000;2(6):477–88.
103. Sanders KM, Ordög T, Koh SD, Torihashi S, Ward SM. Development and
plasticity of interstitial cells of Cajal. Neurogastroenterol Motil. 1999;11(5):311–38.
104. Suarez Rodriguez R, Belkind GJ. Cultured nestin positive cells from postnatal
mouse small bowel differentiate ex vivo into neurons, glia, and smooth
muscle. Stem Cells. 2004;22:1373–85.
105. Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ. Neural
crest stem cells persist in the adult gut but undergo changes in self-
renewal, neuronal subtype potential, and factor responsiveness. Neuron.
2002;35(4):657–69.
106. Heanue T, Pachnis V. Prospective identification and isolation of enteric
nervous system progenitors using Sox2. Stem Cells. 2011;29:128–40.
107. Lake JI, Heuckeroth RO. Enteric nervous system development: migration,
differentiation, and disease. Am J Physiol Gastrointest Liver Physiol.
2013;305(1):G1–24.
108. Joseph NM, He S, Quintana E, Kim YG, Núñez G, Morrison SJ. Enteric glia are
multipotent in culture but primarily form glia in the adult rodent gut. J Clin
Invest. 2011;121(9):3398–411.
109. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural
progenitor identity. Neuron. 2003;39(5):749–65.
110. Richardson WD, Young KM, Tripathi RB, McKenzie I. NG2 glia as multipotent
neural stem cells: fact or fantasy? Neuron. 2011;70:661–73.
111. Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells):
multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009;10(1):9–22.
112. Hwang I, Choi YS, Jeon MY, Jeong S. NF κB p65 represses β catenin
activated transcription of cyclin D1. Biochem Biophys Res Commun.
2010;403(1):79–84.
113. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kemler R. Formation of
multiple hearts in mice following deletion of beta-catenin in the embryonic
endoderm. Dev Cell. 2002;3(2):171–81.
114. Liu L, Rao JN, Zou T, Xiao L, Smith A, Zhuang R, et al. Activation of Wnt3a
signaling stimulates intestinal epithelial repair by promoting c-Myc-
regulated gene expression. Am J Physiol Cell Physiol. 2012;302(1):C277–85.
115. Crosnier C, Stamataki D, Lewis J. Organizing cell renewal in the intestine: stem
cells, signals and combinatorial control. Nat Rev Genet. 2006;7(5):349–59.
116. Kalyani A, Hobson K, Rao MS. Neuroepithelial stem cells from the embryonic
spinal cord: isolation, characterization, and clonal analysis. Dev Biol.
1997;186(2):202–23.
117. Rao MS. Multipotent and restricted precursors in the central nervous
system. Anat Rec. 1999;257(4):137–48.
118. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol.
2001;2:769–76.
119. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, et al.
Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J.
1996;15(23):6541–51.
120. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, et al. Phosphorylation
of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol
Chem. 2007;282(15):11221–9.
121. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of
glycogen synthase kinase 3 by insulin mediated by protein kinase B. Nature.
1995;378(6559):785–9.122. Villanueva S, Glavic A, Ruiz P, Mayor R. Posteriorization by FGF, Wnt, and
retinoic acid is required for neural crest induction. Dev Biol. 2002;241:289–301.
123. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al.
Regulation of neuronal survival by the serine-threonine protein kinase Akt.
Science. 1997;275(5300):661–5.
124. Salinas M, Martin D, Alvarez A, Cuadrado A. Akt1/PKBalpha protects PC12
cells against the parkinsonism inducing neurotoxin 1 methyl 4
phenylpyridinium and reduces the levels of oxygen free radicals. Mol Cell
Neurosci. 2001;17:67–77.
125. Noshita N, Lewén A, Sugawara T, Chan PH. Akt phosphorylation and
neuronal survival after traumatic brain injury in mice. Neurobiol Dis.
2002;9(3):294–304.
126. Humbert S, Bryson EA, Cordelières FP, Connors NC, Datta SR, Finkbeiner S,
et al. The IGF-1/Akt pathway is neuroprotective in Huntington’s disease and
involves Huntingtin phosphorylation by Akt. Dev Cell. 2002;2(6):831–7.
127. Kane LP, Shapiro VS, Stokoe E, Weiss A. Induction of NF kB by the Akt/PKB
kinase. Curr Biol. 1999;9:601–4.
128. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for
glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
Nature. 2000;406(6791):86–90.
129. Anitha M, Vijay Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S. Gut
microbial products regulate murine gastrointestinal motility via toll like
receptor 4 signalling. Gastroenterology. 2012;143(4):1006–16. e4.
130. Cohen P, Goedert M. GSK3 inhibitors: development and therapeutic
potential. Nat Rev Drug Discov. 2004;3(6):479–87.
131. Kozikowski AP, Gaisina IN, Petukhov PA, Sridhar J, King LT, Blond SY, et al.
Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation
and decrease alpha-synuclein protein expression in a cellular model of
Parkinson’s disease. ChemMedChem. 2006;1(2):256–66.
132. Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD,
et al. Deregulated GSK3beta activity in colorectal cancer: its association with
tumor cell survival and proliferation. Biochem Biophys Res Commun.
2005;334(4):1365–73.
133. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, et al.
Inhibition of GSK-3 beta activity attenuates proliferation of human colon
cancer cells in rodents. Cancer Sci. 2007;98(9):1388–93.
134. Ougolkov AV, Fernandez Zapico ME, Savoy DN, Urrutia RA, Billadeau DD.
Glycogen synthase kinase 3beta participates in nuclear factor kappaB
mediated gene transcription and cell survival in pancreatic cancer cells.
Cancer Res. 2005;65(6):2076–81.
135. Cross DA, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD. Selective
small-molecule inhibitors of glycogen synthase kinase-3 activity protect
primary neurones from death. J Neurochem. 2000;77(1):94–102.
136. Culbert AA, Brown MJ, Frame S, Hagen T, Cross DA, Bax B, et al. GSK-3
inhibition by adenoviral FRAT1 overexpression is neuroprotective and
induces Tau dephosphorylation and beta-catenin stabilisation without
elevation of glycogen synthase activity. FEBS Lett. 2001;507(3):288–94.
137. Schaale K, Neumann J, Schneider D, Ehlers S, Reiling N. Wnt signalling in
macrophages: augmenting and inhibiting mycobacteria induced
inflammatory responses. Eur J Cell Biol. 2011;90(6 7):553–9.
138. Li B, Zhong L, Yang X, Andersson T, Huang M, Tang SJ. WNT5A signalling
contributes to Aβ-induced neuroinflammation and neurotoxicity. PLoS One.
2011;6(8):e22920.
139. Li B, Shi Y, Shu J, Gao J, Wu P, Tang SJ. Wingless-type mammary tumor virus
integration site family, member 5A (Wnt5a) regulates human immunodeficiency
virus type 1 (HIV-1) envelope glycoprotein 120 (gp120)-induced expression of
pro-inflammatory cytokines via the Ca2+/calmodulin-dependent protein kinase
II (CaMKII) and c-Jun N-terminal kinase (JNK) signalling pathways. J Biol Chem.
2013;288(19):13610–9.
